These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6538772)

  • 1. In vitro antimicrobial activity of aztreonam alone and in combination against bacterial isolates from pediatric patients.
    Stutman HR; Welch DF; Scribner RK; Marks MI
    Antimicrob Agents Chemother; 1984 Feb; 25(2):212-5. PubMed ID: 6538772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of carumonam.
    Fass RJ; Helsel VL
    Antimicrob Agents Chemother; 1985 Dec; 28(6):834-6. PubMed ID: 4083866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
    Giamarellou H
    Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-formimidoyl thienamycin: in vitro comparison with cefoxitin and tobramycin against clinical, bacterial isolates.
    Digranes A; Dibb WL; Benonisen E
    Acta Pathol Microbiol Immunol Scand B; 1983 Apr; 91(2):141-4. PubMed ID: 6603093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of aztreonam in combination with newer beta-lactams and amikacin against multiply resistant gram-negative bacilli.
    Buesing MA; Jorgensen JH
    Antimicrob Agents Chemother; 1984 Feb; 25(2):283-5. PubMed ID: 6538773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of aztreonam in combination with azlocillin or piperacillin on Pseudomonas aeruginosa.
    Wu DH; Baltch AL; Smith RP; Conley PE
    Antimicrob Agents Chemother; 1984 Oct; 26(4):519-21. PubMed ID: 6440474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activities of antibiotic combinations against clincal isolates of Pseudomonas aeruginosa.
    Chen YH; Peng CF; Lu PL; Tsai JJ; Chen TP
    Kaohsiung J Med Sci; 2004 Jun; 20(6):261-7. PubMed ID: 15253466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antimicrobial activity of piperacillin/tazobactam in comparison with other broad-spectrum beta-lactams.
    Roland RK; Mendes RE; Silbert S; Bolsoni AP; Sader HS
    Braz J Infect Dis; 2000 Oct; 4(5):226-35. PubMed ID: 11063554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of aztreonam against gram negative bacteria from clinical specimens and its comparison with other commonly used antibiotics.
    Qadri SM; Belobraydic KA
    Methods Find Exp Clin Pharmacol; 1986 Apr; 8(4):223-6. PubMed ID: 3088346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial activity of tobramycin against gram-negative bacteria and the combination of ampicillin/tobramycin against E. coli.
    Laxer RM; Mackay E; Marks MI
    Chemotherapy; 1975; 21(2):90-8. PubMed ID: 168040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of moxalactam against pathogenic bacteria and its comparison with other antibiotics.
    Perrymann F; Flournoy DJ; Qadri SM
    Chemotherapy; 1983; 29(1):37-42. PubMed ID: 6219865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro appraisal of piperacillin, including its activity against Salmonella typhi.
    Robinson RG; Saunders J; Cassel R; Block CS; Koornhof HJ
    Antimicrob Agents Chemother; 1980 Oct; 18(4):493-501. PubMed ID: 6449903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro synergy studies using aztreonam and fluoroquinolone combinations against six species of Gram-negative bacilli.
    Critchley IA; Sahm DF; Kelly LJ; Karlowsky JA
    Chemotherapy; 2003 May; 49(1-2):44-8. PubMed ID: 12714810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro studies of investigational beta-lactams as possible therapy for Pseudomonas aeruginosa endocarditis.
    Zar FA; Kany RJ
    Antimicrob Agents Chemother; 1985 Jan; 27(1):1-3. PubMed ID: 3920956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of azthreonam, a monobactam antibiotic.
    Jacobus NV; Ferreira MC; Barza M
    Antimicrob Agents Chemother; 1982 Nov; 22(5):832-8. PubMed ID: 6891198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the activity of cefoperazone, cefuroxime and cefoxitin against Gram-negative bacilli and synergy studies with cefoperazone and ticarcillin.
    Miles HM; Carson M; Pavillard ER
    Drugs; 1981; 22 Suppl 1():15-9. PubMed ID: 6456885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro antimicrobial activity of enoxacin in combination with eight other antibiotics against Pseudomonas aeruginosa, Enterobacteriaceae and Staphylococcus aureus.
    Baltch AL; Bassey C; Fanciullo G; Smith RP
    J Antimicrob Chemother; 1987 Jan; 19(1):45-8. PubMed ID: 3104277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temocillin. In vitro antibacterial activity.
    Slocombe B; Cooper CE; Griffin KE; White AR
    Drugs; 1985; 29 Suppl 5():49-56. PubMed ID: 3849425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomonas aeruginosa: in vitro susceptibility to antimicrobial drugs, single and combined, with and without defibrinated human blood.
    Traub WH; Spohr M; Bauer D
    Chemotherapy; 1988; 34(4):284-97. PubMed ID: 3145172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination effect of antibiotics against bacteria isolated from keratitis using fractional inhibitory concentration index.
    Suzuki T; Ohashi Y
    Cornea; 2013 Jul; 32(7):e156-60. PubMed ID: 23665643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.